Jiangsu Tianyan Pharmaceutical Technology Co., Ltd. announced that it will receive CNY 20,000,000 in a round of funding from new investor Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) on March 30, 2021. The investor will acquire 55% stake along with merger transaction. The transaction has been reviewed and approved at the 23rd meeting of the first board of directors of the investor.